FIELD: medicine.
SUBSTANCE: invention relates to veterinary, namely to parasitology. Application of a pharmaceutical composition, containing n-tetradecyltri-n-butylphosphonium chloride and 5,7-bis-(m-nitroanilino)-4,6-nitrobenzofuroxane as active components with their weight ratio of 1:10 and glucose as an auxiliary substance, as an anti-piroplasmosis medication for the treatment of dogs. The said anti-piroplasmosis medication is introduced orally two times with a 24 hour interval in a dose of 350 mg/kg of live weight. The anti-piroplasmosis medication possesses high anti-parasitic activity and low toxicity (LD50 2500 mg/kg).
EFFECT: invention provides an increase of treatment efficiency.
2 cl, 2 dwg, 2 tbl, 1 ex
| Title | Year | Author | Number |
|---|---|---|---|
| ANTI-EIMERIOSIS PHARMACEUTICAL COMPOSITION BASED ON SALT OF QUARTERNARY PHOSPHONIUM AND SUBSTITUTED DINITROBENZOFUROXANE | 2010 |
|
RU2473334C2 |
| AGENT FOR TREATMENT OF COCCIDIOSIS IN BIRDS AND ANIMALS | 2014 |
|
RU2557889C1 |
| MEDICATION FOR TREATMENT OF DOG'S PYROPLASMOSIS | 2006 |
|
RU2347558C2 |
| METHOD OF TREATING AND PREVENTION OF REINDEER BABESIOSIS | 2012 |
|
RU2473338C1 |
| METHOD OF TREATING BABESIASIS IN DOGS | 2008 |
|
RU2407542C2 |
| ACARICIDAL PHARMACEUTICAL COMPOSITION OF QUATERNARY PHOSPHONIUM SALTS, SUBSTITUTED DINITROBENZOFURAXAN AND XYMEDON HYDROCHLORIDE | 2012 |
|
RU2497508C2 |
| PREPARATION FOR TREATING FELINE HEMOBARTONELLOSIS AND METHOD FOR ITS APPLICATION | 2003 |
|
RU2254123C2 |
| METHOD OF TREATING DOGS WITH BABESIASIS AND PRODUCING PREPARATION OF MALE BEE LARVAE AND BEET JUICE FOR TREATING THEM | 2013 |
|
RU2545891C2 |
| PHARMACEUTICAL COMPOSITION FOR VETERINARY MEDICINE AND MEDICINE WITH ANTIPARASITIC EFFICACY | 2022 |
|
RU2802022C1 |
| MEANS FOR NEMATODOSIS AND EIMERIOSIS TREATMENT IN VETERINARY | 2017 |
|
RU2629316C1 |
